Skip to main content
Premium Trial:

Request an Annual Quote

Centogene, Alector Partner to ID Frontotemporal Dementia Patients With Genetic Mutations

NEW YORK – Centogene said on Wednesday that it has partnered with biotechnology firm Alector on an observational study to identify frontotemporal dementia patients with genetic mutations.

Alector, a South San Francisco-based immuno-neurology company developing treatments for neurodegenerative diseases, will provide undisclosed financial support for the effort.

The study, called EFRONT, aims to enroll more than 3,000 FTD patients for genetic testing at centers in Belgium, Germany, Greece, Italy, Portugal, Spain, and Turkey.

"The study will take full advantage of the power of Centogene's unique bio/databank, expertise in neuroscience, and extensive network of neurologists," said Centogene CEO Andrin Oswald in a statement.

“In line with our commitment to improving the lives of patients with frontotemporal dementia, we are pleased to support Centogene's efforts to advance a better and more comprehensive understanding of the genetic underpinnings of FTD through the observational EFRONT study," said Robert Paul, chief medical officer of Alector.

FTD, which currently has no treatments, affects approximately 110,000 patients in the European Union and more than 50,000 in the US. Between 5 and 10 percent of FTD patients harbor a mutation in the progranulin gene, according to Rostock, Germany-based Centogene, and for many others, the disease cause is thought to be genetic.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.